Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial
Agenzia Italiana del Farmaco, Ministero della Salute
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial
Donatella Bloise, Vittorio Venditti, Mario Fontana, Diego Bailetti et al.
Journal
BMC Medicine
Topics
Bone health and osteoporosis research
article
Effect of sitagliptin vs. placebo on bone mineralization in women with type 2 diabetes: the SLowDOWN (SitagLiptin in Diabetes for Osteoporosis in WomeN) randomized clinical trial
Donatella Bloise, Vittorio Venditti, Mario Fontana, Diego Bailetti, Carla Lubrano, Flavia Agata Cimini, Arianna Dellanno, Giulia Passarella, Federica Sentinelli, Nicola Napoli, Ilaria Barchetta, Alessandra Soriani, Susanna Morano, Tiziana Filardi, Antonio Angeloni, Sara Dule, Emanuela Anastasi, Laura Bertoccini, Margherita Palermo, Andrea Lenzi, Orietta Gandini, Maria Gisella Cavallo, Enrico Bleve, Marcello Arca, Elisabetta Romagnoli, Marco Giorgio Baroni, Maria Luongo, Lorenzo Cuollo, Maria Neve Hirsch, Antonio Nicolucci, Maria Chiara Rossi, Giuseppe Lucisano, Lelio Morviducci, Alessandro Oldani
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 23(1)
Institutions
Università Campus Bio-Medico (IT), University of L'Aquila (IT), Istituto Neurologico Mediterraneo (IT), ASL Roma (IT), Ospedale di Santo Spirito (IT), Nini Hospital (LB), Center for Outcomes Research and Clinical Epidemiology (IT), Sapienza University of Rome (IT)
Funders
Agenzia Italiana del Farmaco, Ministero della Salute